Qiagen Reports 5 Percent Q2 Revenue Spike; Beats Analyst Estimates | GenomeWeb

This article has been update from a previous version to include comments made by Qiagen CEO Peer Schatz during the company's earnings call.

NEW YORK (GenomeWeb) – Qiagen said after the close of the market Thursday that its second quarter revenues grew 5 percent year over year as the company beat analysts' consensus estimate on the top and bottom lines.

For the three months ended June 30, Qiagen reported net sales of $334.4 million, exceeding the Wall Street estimate of $326.8 million. At constant exchange rates, Q2 revenues increased 6 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.